PetVivo's Strategic Move: Meet Dr. Kirsty Husby, Senior Vet
PetVivo Welcomes Dr. Kirsty Husby to Enhance Veterinary Services
PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical company that specializes in innovative therapeutic devices for the treatment of equines and companion animals, is thrilled to announce the appointment of Dr. Kirsty Husby as their Senior Technical Services Veterinarian. Dr. Husby’s expertise is expected to significantly contribute to the growing adoption of Spryng™, a breakthrough treatment targeting osteoarthritis in companion animals.
Expertise in Animal Health
Dr. Husby brings over ten years of rich experience in animal health, including clinical practice and academic excellence from notable institutions such as Columbia Equine Clinic and Oregon State University. Her vast background is set to bolster PetVivo’s commitment to enhancing animal health and wellbeing.
“Dr. Husby’s unique qualifications in both equine and small animal veterinary care greatly enrich our professional team,” stated CEO John Lai. “Her role is pivotal in promoting our flagship product, Spryng with OsteoCushion™ Technology, among veterinarians, broadening their understanding of the product's benefits and increasing its usage.”
Impact of Spryng™ in Veterinary Care
The spread of Spryng™ has reached over 800 veterinary clinics across various states, leading to more than 10,000 Spryng syringes distributed nationwide. This exponential increase in usage is already making a positive difference in the lives of countless animals, leading to projections that PetVivo could potentially double its current fiscal year revenue.
The Vision Moving Forward
Dr. Husby expressed her enthusiasm about joining PetVivo at such a crucial juncture in its growth. She emphasizes her mission to leverage her knowledge to enhance the quality of life for animals suffering from osteoarthritis and related conditions through effective application of Spryng™. Her efforts will ensure that veterinarians have access to the knowledge necessary to utilize Spryng™ effectively.
Dr. Kirsty Husby's Professional Journey
As a board-certified equine surgeon and small animal veterinarian, Dr. Husby has held crucial positions in various esteemed veterinary clinics and institutions. Her previous roles include medical director at Cascade Animal Clinic and equine surgeon at leading facilities such as Columbia Equine Hospital.
Academic Excellence
Dr. Husby completed her veterinary education at Iowa State University and further advanced her expertise through specialized internships and fellowships. She not only achieved her Doctor of Veterinary Medicine but also holds a Master of Veterinary Science from Oregon State University, showcasing her deep commitment to animal health.
About PetVivo Holdings, Inc.
PetVivo Holdings focuses on creating, commercializing, and licensing pioneering medical devices for companion animals. As part of its strategic vision, the company aims to accelerate the development timelines for veterinary medical devices, which can enable quicker pathways to revenue compared to more strictly regulated human medical products.
With a growing portfolio of 21 patents, the company is poised for significant influence in both the animal and human health sectors. Its flagship product, Spryng™, represents a significant technological advancement for veterinary care, allowing for intra-articular injections that target not just lameness but a range of joint conditions, thereby improving the quality of life in animals.
Frequently Asked Questions
What is Spryng™ and how does it help animals?
Spryng™ is an innovative veterinary medical device designed to provide relief from lameness and joint-related problems, including osteoarthritis, for dogs, cats, and horses.
Who is Dr. Kirsty Husby?
Dr. Kirsty Husby is a board-certified veterinary surgeon with over ten years of experience in animal health, recently appointed as the Senior Technical Services Veterinarian at PetVivo.
What role will Dr. Husby play at PetVivo?
Dr. Husby will work to increase the understanding and adoption of Spryng™ among veterinary professionals, helping to enhance animal care.
How has Spryng™ been received in the market?
Spryng™ has been adopted by over 800 veterinary clinics across the country, demonstrating its effectiveness and potential for significant impact in veterinary medicine.
How can I get in touch with PetVivo?
For inquiries about PetVivo and its products, you can email info1@petvivo.com or visit their website at petvivo.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.